Early research (Phase 1)Study completedNCT00757939
What this trial is testing
Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 40